197 related articles for article (PubMed ID: 2526885)
21. [Automation of colorimetry using chromogenic substrates, with special reference to blood coagulation disorders in acute myelocytic leukemia].
Hashizume K; Tanaki T; Horita H; Yoshitani H; Kumatani Y; Matsuda T; Ito K
Rinsho Byori; 1985 Feb; Spec No 61():114-8. PubMed ID: 3858561
[No Abstract] [Full Text] [Related]
22. [Changes in coagulation and fibrinolysis cascades upon extracorporeal circulation].
Kanamori N; Koiwa F; Uda S
Nihon Rinsho; 1991 Dec; 49 Suppl():81-6. PubMed ID: 1839690
[No Abstract] [Full Text] [Related]
23. [Molecular markers of hemostatic-mechanisms--plasmin-alpha 2 plasmin inhibitor complex].
Kawai Y; Watanabe K
Rinsho Byori; 1989 Mar; 37(3):248-55. PubMed ID: 2526263
[No Abstract] [Full Text] [Related]
24. Studies on changes in parameters of the coagulation and fibrinolysis in association with extracorporeal shock wave lithotripsy.
Umekawa T; Kohri K; Yamate T; Amasaki N; Ishikawa Y; Kurita T
Urol Int; 1993; 50(3):159-63. PubMed ID: 8465483
[TBL] [Abstract][Full Text] [Related]
25. Study of the balance between coagulation and fibrinolysis in disseminated intravascular coagulation using molecular markers.
Asakura H; Jokaji H; Saito M; Uotani C; Kumabashiri I; Morishita E; Yamazaki M; Aoshima K; Matsuda T
Blood Coagul Fibrinolysis; 1994 Oct; 5(5):829-32. PubMed ID: 7865691
[TBL] [Abstract][Full Text] [Related]
26. Activation patterns of coagulation and fibrinolysis in baboons following infusion with lethal or sublethal dose of Escherichia coli.
de Boer JP; Creasy AA; Chang A; Roem D; Brouwer MC; Eerenberg AJ; Hack CE; Taylor FB
Circ Shock; 1993 Jan; 39(1):59-67. PubMed ID: 7683256
[TBL] [Abstract][Full Text] [Related]
27. Postangioplasty restenosis: platelet activation and the coagulation-fibrinolysis system as possible factors in the pathogenesis of restenosis.
Ishiwata S; Tukada T; Nakanishi S; Nishiyama S; Seki A
Am Heart J; 1997 Apr; 133(4):387-92. PubMed ID: 9124158
[TBL] [Abstract][Full Text] [Related]
28. [Significance of factors of coagulation and fibrinolysis in progression of lung cancer].
Nagayama M; Tachibana A; Hayakawa H; Sato A
Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Feb; 31(2):180-5. PubMed ID: 8390588
[TBL] [Abstract][Full Text] [Related]
29. Plasmin-alpha 2-plasmin inhibitor complex in plasma of patients with disseminated intravascular coagulation.
Takahashi H; Hanano M; Takizawa S; Tatewaki W; Shibata A
Am J Hematol; 1988 Jul; 28(3):162-6. PubMed ID: 2457307
[TBL] [Abstract][Full Text] [Related]
30. Activation of coagulation and fibrinolysis during treatment with OKT3.
ten Berge RJ; Raasveld MH; van Diepen FN; Hack CE
Transplant Proc; 1993 Feb; 25(1 Pt 1):566-7. PubMed ID: 8438416
[No Abstract] [Full Text] [Related]
31. Imbalance between thrombin and plasmin activity in disseminated intravascular coagulation. Assessment by the thrombin-antithrombin-III complex/plasmin-alpha-2-antiplasmin complex ratio.
Kario K; Matsuo T; Kodama K; Matsuo M; Yamamoto K; Kobayashi H
Haemostasis; 1992; 22(4):179-86. PubMed ID: 1468720
[TBL] [Abstract][Full Text] [Related]
32. [The significance of measurement of alpha 2PI-plasmin complex in acute promyelocytic leukemia].
Asakura H; Itoh K; Johkaji Y; Saito M; Uotani C; Kumabashiri I; Matsuda T
Rinsho Ketsueki; 1988 Apr; 29(4):534-8. PubMed ID: 2969985
[No Abstract] [Full Text] [Related]
33. Increased vascular endothelial cell markers in patients with disseminated intravascular coagulation.
Wada H; Minamikawa K; Wakita Y; Nakase T; Kaneko T; Ohiwa M; Tamaki S; Deguchi K; Shirakawa S; Hayashi T
Am J Hematol; 1993 Oct; 44(2):85-8. PubMed ID: 8266924
[TBL] [Abstract][Full Text] [Related]
34. Early markers of blood coagulation and fibrinolysis activation in Argentine hemorrhagic fever.
Heller MV; Marta RF; Sturk A; Maiztegui JI; Hack CE; Cate JW; Molinas FC
Thromb Haemost; 1995 Mar; 73(3):368-73. PubMed ID: 7667817
[TBL] [Abstract][Full Text] [Related]
35. Changes in the coagulation and fibrinolytic systems during and after cardiopulmonary bypass surgery.
Kongsgaard UE; Smith-Erichsen N; Geiran O; Bjørnskau L
Thorac Cardiovasc Surg; 1989 Jun; 37(3):158-62. PubMed ID: 2527423
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of the coagulation and fibrinolytic systems in men with intermittent claudication.
Handa K; Takao M; Nomoto J; Oku K; Shirai K; Saku K; Arakawa K
Angiology; 1996 Jun; 47(6):543-8. PubMed ID: 8678328
[TBL] [Abstract][Full Text] [Related]
37. Factors and inhibitors of blood coagulation and fibrinolysis in promyelocytic leukemia.
Bratt G; Blombäck M; Lockner D
Scand J Clin Lab Invest Suppl; 1985; 178():81-3. PubMed ID: 3937221
[No Abstract] [Full Text] [Related]
38. Time course of clotting and fibrinolytic markers in acute upper gastrointestinal bleeding: relation to diagnosis and blood transfusion treatment.
Henriksson AE; Nilsson TK; Svensson JO
Blood Coagul Fibrinolysis; 1993 Dec; 4(6):877-80. PubMed ID: 7511945
[TBL] [Abstract][Full Text] [Related]
39. Disseminated intravascular coagulation in transfusion-associated graft-versus-host disease. Report of two cases.
Murakawa M; Okamura T; Harada M; Esaki T; Kamura T; Shibuya T; Niho Y
Ann Clin Lab Sci; 1995; 25(1):31-8. PubMed ID: 7762966
[TBL] [Abstract][Full Text] [Related]
40. The immunochemical determination of thrombin-antithrombin III and plasmin-antiplasmin complexes in human plasma.
Collen D
Verh K Acad Geneeskd Belg; 1979; 41(2):81-166. PubMed ID: 160714
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
